Your Messages Inbox
Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. Pre-participation screening of young competitive athletes for prevention of sudden cardiac death 3. The Job Market for 2008-2009: Compensation 4. Renal Artery Stenosis 5. AHA Guidelines on Cardiac CT for Assessing Coronary Artery Disease
Your Article Summary
See Latest ArticlesCatheter-Based Delivery of Fluid Paclitaxel for Prevention of Restenosis in Native Coronary Artery Lesions After Stent Implantation
Circulation: Cardiovascular Interventions, 07/24/09
Herdeg C et al. – Additional antiproliferative treatment of de novo lesions in native coronary arteries with catheter–based delivery of fluid paclitaxel after bare metal stenting was safe and significantly reduced neointimal proliferation, restenosis, and clinical events compared with bare metal stent implantation alone.
Related Articles
C-Reactive Protein and the Risk of Stent Thrombosis and Cardiovascular Events After Drug-Eluting Stent Implantation
Circulation, 11/04/09
Relevance Score: 68%
Intravascular Ultrasound Assessment of the Incidence and Predictors of Edge Dissections After Drug-Eluting Stent Implantation
JACC - Journal of the American College of Cardiology: Cardiovascular Interventions, 10/23/09
Relevance Score: 68%
Symptoms Related to Ureteral Stents in Renal Transplants Compared with Stents Placed for Other Indications
Journal of Endourology, 10/23/09
Relevance Score: 68%
Degradable and drug-eluting stents: Mixed results
Urology Times, 11/04/09
Relevance Score: 67%
Optimal Stent-Sizing With Intravascular Ultrasound Contributes to Complete Neointimal Coverage After Sirolimus-Eluting Stent Implantation Assessed by Angioscopy
JACC - Journal of the American College of Cardiology: Cardiovascular Interventions, 10/23/09
Relevance Score: 67%
Today in Clinical Pharmacology...keeping you current
Receive free subspecialty "5-minute updates" via email
Management of hypertension with fixed dose combinations of candesartan cilexetil and hydrochlorothiazide: patient perspectives and clinical utility
Vascular Health and Risk Management, 12/01/09
The Antiplatelet Effect of Aspirin is Reduced by Proton Pump Inhibitors in Patients With Coronary Artery Disease
Heart, 12/01/09
Vernakalant hydrochloride for the treatment of atrial fibrillation
Expert Opinion on Investigational Drugs, 11/30/09
Today in Coronary Artery Disease...keeping you current
Receive free subspecialty "5-minute updates" via email
Relationship between the EQ-5D index and measures of clinical outcomes in selected studies of cardiovascular interventions
Health and Quality of Life Outcomes , 12/01/09
Impact of Glucose Tolerance Status on Development of Ischemic Stroke and Coronary Heart Disease in a General Japanese Population. The Hisayama Study
Stroke, 12/01/09
TCF7L2 Polymorphism rs7903146 Is Associated with Coronary Artery Disease Severity and Mortality
PLoS ONE - Cardiovascular Disorders, 12/01/09
Today in Interventional...keeping you current
Receive free subspecialty "5-minute updates" via email
Relationship Between Baseline Inflammatory Markers, Antiplate let Therapy, and Adverse Cardiac Events After Percutaneous Coronary Intervention
Circulation: Cardiovascular Interventions, 11/24/09
Prognostic Impact of Periprocedural Bleeding and Myocardial Infarction After Percutaneous Coronary Intervention in Unselected Patients
JACC - Journal of the American College of Cardiology: Cardiovascular Interventions, 11/20/09
Early Experience with a Simplified Technique for Transcatheter Closure of the Patent Foramen Ovale
Heart, Lung, and Circulation, 11/20/09
Today in Prevention...keeping you current
Receive free subspecialty "5-minute updates" via email
Bone Mineral Density: What Is Its Relationship to Heart Disease?
Geriatrics & Aging, 12/01/09
Cardiovascular disease risk of dietary stearic acid compared with trans, other saturated, and unsaturated fatty acids: a systematic review
American Journal of Clinical Nutrition, 12/01/09
Low-Density Lipoprotein Cholesterol Reduction and Goal Achievement With Ezetimibe/Simvastatin Versus Atorvastatin or Rosuvastatin in Patients With Diabetes, Metabolic Syndrome, or Neither Disease, Stratified By National Cholesterol Education Program Risk Category
Metabolic Syndrome and Related Disorders, 11/30/09
Sponsor
Article Search
Sponsor
Sponsor